首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Levonorgestrel intrauterine system versus thermal balloon ablation for the treatment of heavy menstrual bleeding: A meta-analysis of randomized controlled trials
【2h】

Levonorgestrel intrauterine system versus thermal balloon ablation for the treatment of heavy menstrual bleeding: A meta-analysis of randomized controlled trials

机译:左炔诺孕酮宫腔内系统与热球囊切除术治疗月经大量出血:随机对照试验的荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

At present, there have been no standard research outcomes as to whether the levonorgestrel intrauterine system (LNG-IUS) or thermal balloon ablation (TBA) is superior for the treatment of patients suffering from heavy menstrual bleeding (HMB). Therefore, in the present study, a meta-analysis of randomized controlled trials (RCTs) was conducted in order to compare the effectiveness and affordability of the LNG-IUS with TBA in the treatment of HMB. A literature search of the following electronic databases was conducted: PubMed, EMBASE, the Cochrane Library, Google Scholar, the Chinese Scientific Journals Database, and the China National Knowledge Infrastructure; and a statistical analysis was performed using RevMan 5.2 software. Seven RCTs involving 467 patients (235 LNG-IUS, 232 TBA) met the inclusion criteria for the present study. As assessed by pictorial blood loss assessment chart (PBAC) scores, the LNG-IUS significantly reduced menstrual bleeding after 24 months [standardized mean difference (SMD), −0.86; 95% confidence interval (CI), −1.22 to −0.50; P<0.00001]. Furthermore, the total treatment cost of the LNG-IUS was lower than that of TBA (SMD, −2.35; 95% CI, −2.98 to −1.72; P<0.00001). However, at the 24 month follow-up, side effects such as amenorrhea occurred more frequently in patients treated with the LNG-IUS, as compared with TBA (relative risk, 2.49; 95% CI, 1.46–4.25; P=0.0008). No significant differences in hemoglobin levels and quality of life were demonstrated between the two treatment groups. The results of the present meta-analysis suggest that the LNG-IUS may be more effective and affordable than TBA as a long-term treatment (24 months) for HMB. However, following 12–24 months of treatment, side effects such as amenorrhea may be more frequent in patients treated with the LNG-IUS. When considering short-term treatment for HMB, controversy remains regarding the two methods and further studies are required to precisely evaluate the outcomes.
机译:目前,尚无关于左炔诺孕酮子宫内系统(LNG-IUS)或热气球消融(TBA)在治疗月经量大出血(HMB)方面是否优越的标准研究成果。因此,在本研究中,进行了一项荟萃分析,以比较LNG-IUS和TBA在HMB治疗中的有效性和可负担性。对以下电子数据库进行了文献检索:PubMed,EMBASE,Cochrane图书馆,Google Scholar,中文科学期刊数据库和中国国家知识基础设施;并使用RevMan 5.2软件进行统计分析。涉及467例患者(235例LNG-IUS,232例TBA)的7个RCT符合本研究的纳入标准。如通过失血量评估图(PBAC)评分所评估,LNG-IUS在24个月后可显着减少月经出血[标准均数差(SMD)为-0.86; 95%置信区间(CI),-1.22至-0.50; P <0.00001]。此外,LNG-IUS的总治疗成本低于TBA(SMD,-2.35; 95%CI,-2.98至-1.72; P <0.00001)。但是,在24个月的随访中,与TBA相比,LNG-IUS治疗的患者更经常发生闭经等副作用(相对风险为2.49; 95%CI为1.46–4.25; P = 0.0008)。两个治疗组之间的血红蛋白水平和生活质量没有显着差异。本荟萃分析的结果表明,作为HMB的长期治疗(24个月),LNG-IUS可能比TBA更有效,更实惠。但是,在接受12-24个月的治疗后,使用LNG-IUS治疗的患者可能会更常见诸如闭经的副作用。在考虑对HMB进行短期治疗时,关于这两种方法仍存在争议,需要进一步研究以准确评估结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号